Retroviral display of urokinase-binding domain fused to amphotropic envelope protein

Biochemical and Biophysical Research Communications

Volumn 331, Issue 4, 2005, Pages 1485-1493

  Boucquey, Antoine ^a   Vilhardt, Frederik ^c   Mitrovic, Tatjana ^a,d   Franco, Dominique ^a,b   Weber, Anne ^a   Horellou, Philippe ^a  

^a INSERM   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

Caveolae; Endocytosis; Gene therapy; Retrovirus; Targeting; Tumor; Urokinase receptor

Indexed keywords

HYBRID PROTEIN; RETROVIRUS VECTOR; UROKINASE; UROKINASE RECEPTOR; VIRUS ENVELOPE PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CAVEOLA; CELL INFILTRATION; CELL LINE; CHIMERA; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ANALYSIS; ENZYME BINDING; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RETROVIRUS; TARGET CELL; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION;

UNIDENTIFIED RETROVIRUS;

EID: 18844403581     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.04.075     Document Type: Article

References (62)

1. L. Cam, A. Boucquey, A. Coulomb-L'hermine, A. Weber, and P. Horellou Gene transfer of constitutively active caspase-3 induces apoptosis in a human hepatoma cell line J. Gene Med. 7 2005 30 38
2. J. Qiao, and M. Caruso PG13 packaging cells produce recombinant retroviruses carrying a diphtheria toxin mutant which kills cancer cells J. Virol. 76 2002 7343 7348
3. K. Xie, S. Huang, Z. Dong, S.H. Juang, M. Gutman, Q.W. Xie, C. Nathan, and I.J. Fidler Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells J. Exp. Med. 181 1995 1333 1343
4. A.R. Kianmanesh, H. Perrin, Y. Panis, M. Fabre, H.J. Nagy, D. Houssin, and D. Klatzmann A "distant" bystander effect of suicide gene therapy: regression of nontransduced tumors together with a distant transduced tumor Hum. Gene Ther. 8 1997 1807 1814
5. R. Gerolami, J. Cardoso, M. Lewin, M.P. Bralet, A. Sa Cunha, O. Clement, C. Brechot, and P.L. Tran Evaluation of HSV-tk gene therapy in a rat model of chemically induced hepatocellular carcinoma by intratumoral and intrahepatic artery routes Cancer Res. 60 2000 993 1001
6. M. Barajas, G. Mazzolini, G. Genove, R. Bilbao, I. Narvaiza, V. Schmitz, B. Sangro, I. Melero, C. Qian, and J. Prieto Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12 Hepatology 33 2001 52 61
7. X. Danthinne, K. Aoki, A.L. Kurachi, G.J. Nabel, and E.G. Nabel Combination gene delivery of the cell cycle inhibitor p27 with thymidine kinase enhances prodrug cytotoxicity J. Virol. 72 1998 9201 9207
8. T. Roe, T.C. Reynolds, G. Yu, and P.O. Brown Integration of murine leukemia virus DNA depends on mitosis EMBO J. 12 1993 2099 2108
9. R.C. Mulligan The basic science of gene therapy Science 260 1993 926 932
10. B.S. Schnierle, D. Moritz, M. Jeschke, and B. Groner Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles Gene Ther. 3 1996 334 342
11. T. Yajima, T. Kanda, K. Yoshiike, and Y. Kitamura Retroviral vector targeting human cells via c-Kit-stem cell factor interaction Hum. Gene Ther. 9 1998 779 787
12. M. Marin, D. Noel, S. Valsesia-Wittman, F. Brockly, M. Etienne-Julan, S. Russell, F.L. Cosset, and M. Piechaczyk Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins J. Virol. 70 1996 2957 2962
13. H. Konishi, T. Ochiya, K.A. Chester, R.H. Begent, T. Muto, T. Sugimura, and M. Terada Targeting strategy for gene delivery to carcinoembryonic antigen-producing cancer cells by retrovirus displaying a single-chain variable fragment antibody Hum. Gene Ther. 9 1998 235 248
14. P.D. Khare, L. Shao-Xi, M. Kuroki, Y. Hirose, F. Arakawa, K. Nakamura, and Y. Tomita Specifically targeted killing of carcinoembryonic antigen (CEA)-expressing cells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase Cancer Res. 61 2001 370 375
15. F.L. Cosset, and S.J. Russell Targeting retrovirus entry Gene Ther. 3 1996 946 956
16. C.A. Benedict, R.Y. Tun, D.B. Rubinstein, T. Guillaume, P.M. Cannon, and W.F. Anderson Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion Hum. Gene Ther. 10 1999 545 557
17. D. Lavillette, S.J. Russell, and F.L. Cosset Retargeting gene delivery using surface-engineered retroviral vector particles Curr. Opin. Biotechnol. 12 2001 461 466
18. M.P. Kavanaugh, and D. Kabat Identification and characterization of a widely expressed phosphate transporter/retrovirus receptor family Kidney Int. 49 1996 959 963
19. F.L. Cosset, Y. Takeuchi, J.L. Battini, R.A. Weiss, and M.K. Collins High-titer packaging cells producing recombinant retroviruses resistant to human serum J. Virol. 69 1995 7430 7436
20. A.K. Fielding, M. Maurice, F.J. Morling, F.L. Cosset, and S.J. Russell Inverse targeting of retroviral vectors: selective gene transfer in a mixed population of hematopoietic and nonhematopoietic cells Blood 91 1998 1802 1809
21. M.P. Chadwick, F.J. Morling, F.L. Cosset, and S.J. Russell Modification of retroviral tropism by display of IGF-I J. Mol. Biol. 285 1999 485 494
22. K.W. Peng, F.J. Morling, F.L. Cosset, G. Murphy, and S.J. Russell A gene delivery system activatable by disease-associated matrix metalloproteinases Hum. Gene Ther. 8 1997 729 738
23. K.W. Peng, R. Vile, F.L. Cosset, and S. Russell Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors Gene Ther. 6 1999 1552 1557
24. T.H. Nguyen, N. Loux, I. Dagher, C. Vons, K. Carey, P. Briand, M. Hadchouel, D. Franco, J. Jouanneau, R. Schwall, and A. Weber Improved gene transfer selectivity to hepatocarcinoma cells by retrovirus vector displaying single-chain variable fragment antibody against c-Met Cancer Gene Ther. 10 2003 840 849
25. J.D. Vassalli, and M.S. Pepper Tumour biology. Membrane proteases in focus Nature 370 1994 14 15
26. P.H. Quax, J.M. Grimbergen, M. Lansink, A.H. Bakker, M.C. Blatter, D. Belin, V.W. van Hinsbergh, and J.H. Verheijen Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding Arterioscler. Thromb. Vasc. Biol. 18 1998 693 701
27. F.L. Cosset, F.J. Morling, Y. Takeuchi, R.A. Weiss, M.K. Collins, and S.J. Russell Retroviral retargeting by envelopes expressing an N-terminal binding domain J. Virol. 69 1995 6314 6322
28. F. Vilhardt, M. Nielsen, K. Sandvig, and B. van Deurs Urokinase-type plasminogen activator receptor is internalized by different mechanisms in polarized and nonpolarized Madin-Darby canine kidney epithelial cells Mol. Biol. Cell 10 1999 179 195
29. L. Nelles, H.R. Lijnen, D. Collen, and W.E. Holmes Characterization of recombinant human single chain urokinase-type plasminogen activator mutants produced by site-specific mutagenesis of lysine 158 J. Biol. Chem. 262 1987 5682 5689
30. L. Naldini, L. Tamagnone, E. Vigna, M. Sachs, G. Hartmann, W. Birchmeier, Y. Daikuhara, H. Tsubouchi, F. Blasi, and P.M. Comoglio Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor EMBO J. 11 1992 4825 4833
31. R.R. Schleef, and C.R. Birdwell The effect of proteases on endothelial cell migration in vitro Exp. Cell Res. 141 1982 503 508
32. T.H. Nguyen, J.C. Pages, D. Farge, P. Briand, and A. Weber Amphotropic retroviral vectors displaying hepatocyte growth factor-envelope fusion proteins improve transduction efficiency of primary hepatocytes Hum. Gene Ther. 9 1998 2469 2479
33. M.R. Stratton, J. Darling, G.J. Pilkington, P.L. Lantos, B.R. Reeves, and C.S. Cooper Characterization of the human cell line TE671 Carcinogenesis 10 1989 899 905
34. J. Pollanen, A. Vaheri, H. Tapiovaara, E. Riley, K. Bertram, G. Woodrow, and R.W. Stephens Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor Proc. Natl. Acad. Sci. USA 87 1990 2230 2234
35. P.A. Andreasen, R. Egelund, and H.H. Petersen The plasminogen activation system in tumor growth, invasion, and metastasis Cell. Mol. Life Sci. 57 2000 25 40
36. J.L. Battini, P. Rodrigues, R. Muller, O. Danos, and J.M. Heard Receptor-binding properties of a purified fragment of the 4070A amphotropic murine leukemia virus envelope glycoprotein J. Virol. 70 1996 4387 4393
37. A. Estreicher, A. Wohlwend, D. Belin, W.D. Schleuning, and J.D. Vassalli Characterization of the cellular binding site for the urokinase-type plasminogen activator J. Biol. Chem. 264 1989 1180 1189
38. U. Bayraktutan, and P. Jones Expression of the human gene encoding urokinase plasminogen activator receptor is activated by disruption of the cytoskeleton Exp. Cell Res. 221 1995 486 495
39. B.H. Nilson, F.J. Morling, F.L. Cosset, and S.J. Russell Targeting of retroviral vectors through protease-substrate interactions Gene Ther. 3 1996 280 286
40. S. Mayor, K.G. Rothberg, and F.R. Maxfield Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking Science 264 1994 1948 1951
41. A. Stahl, and B.M. Mueller The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae J. Cell Biol. 129 1995 335 344
42. G.C. Gellert, R.P. Kitson, and R.H. Goldfarb Urokinase-type plasminogen activator receptor crosslinking in an NK cell line increases integrin surface expression by the MAP kinase/ERK 1/2 signaling pathway J. Cell. Biochem. 89 2003 279 288
43. F.F. Bolander Jr. Requirements for mouse mammary tumour virus internalization in mouse mammary epithelial cells J. Gen. Virol. 77 Pt. 4 1996 793 796
44. S.E. Kuhmann, E.J. Platt, S.L. Kozak, and D. Kabat Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1 J. Virol. 74 2000 7005 7015
45. D.C. Siess, S.L. Kozak, and D. Kabat Exceptional fusogenicity of Chinese hamster ovary cells with murine retroviruses suggests roles for cellular factor(s) and receptor clusters in the membrane fusion process J. Virol. 70 1996 3432 3439
46. P. Thomsen, K. Roepstorff, M. Stahlhut, and B. van Deurs Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking Mol. Biol. Cell 13 2002 238 250
47. E. Yamada The fine structure of the gall bladder epithelium of the mouse J. Biophys. Biochem. Cytol. 1 1955 445 458
48. R.G. Anderson The caveolae membrane system Annu. Rev. Biochem. 67 1998 199 225
49. K. Simons, and E. Ikonen Functional rafts in cell membranes Nature 387 1997 569 572
50. R.G. Anderson Potocytosis of small molecules and ions by caveolae Trends Cell Biol. 3 1993 69 72
51. S. Mayor, S. Sabharanjak, and F.R. Maxfield Cholesterol-dependent retention of GPI-anchored proteins in endosomes EMBO J. 17 1998 4626 4638
52. R. Gagescu, N. Demaurex, R.G. Parton, W. Hunziker, L.A. Huber, and J. Gruenberg The recycling endosome of Madin-Darby canine kidney cells is a mildly acidic compartment rich in raft components Mol. Biol. Cell 11 2000 2775 2791
53. D. Hailstones, L.S. Sleer, R.G. Parton, and K.K. Stanley Regulation of caveolin and caveolae by cholesterol in MDCK cells J. Lipid Res. 39 1998 369 379
54. S.K. Rodal, G. Skretting, O. Garred, F. Vilhardt, B. van Deurs, and K. Sandvig Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles Mol. Biol. Cell 10 1999 961 974
55. A. Balbis, G. Baquiran, C. Mounier, and B.I. Posner Effect of insulin on caveolin-enriched membrane domains in rat liver J. Biol. Chem. 279 2004 39348 39357
56. L. Pelkmans, and A. Helenius Insider information: what viruses tell us about endocytosis Curr. Opin. Cell Biol. 15 2003 414 422
57. L. Pelkmans, J. Kartenbeck, and A. Helenius Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER Nat. Cell Biol. 3 2001 473 483
58. L.J. Katen, M.M. Januszeski, W.F. Anderson, K.J. Hasenkrug, and L.H. Evans Infectious entry by amphotropic as well as ecotropic murine leukemia viruses occurs through an endocytic pathway J. Virol. 75 2001 5018 5026
59. A. Alfsen, P. Iniguez, E. Bouguyon, and M. Bomsel Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1 J. Immunol. 166 2001 6257 6265
60. S.N. Asin, M.W. Fanger, D. Wildt-Perinic, P.L. Ware, C.R. Wira, and A.L. Howell Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts J. Infect. Dis. 190 2004 236 245
61. S. Venkatesan, J.J. Rose, R. Lodge, P.M. Murphy, and J.F. Foley Distinct mechanisms of agonist-induced endocytosis for human chemokine receptors CCR5 and CXCR4 Mol. Biol. Cell 14 2003 3305 3324
62. S. Manes, G. del Real, R.A. Lacalle, P. Lucas, C. Gomez-Mouton, S. Sanchez-Palomino, R. Delgado, J. Alcami, E. Mira, and A.C. Martinez Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection EMBO Rep. 1 2000 190 196